Clinical trials
Completed Phase 2 trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,541 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 15 |
| 2001 | 30 |
| 2002 | 50 |
| 2003 | 55 |
| 2004 | 66 |
| 2005 | 92 |
| 2006 | 110 |
| 2007 | 110 |
| 2008 | 124 |
| 2009 | 130 |
| 2010 | 128 |
| 2011 | 146 |
| 2012 | 135 |
| 2013 | 120 |
| 2014 | 140 |
| 2015 | 138 |
| 2016 | 142 |
| 2017 | 153 |
| 2018 | 136 |
| 2019 | 118 |
| 2020 | 92 |
| 2021 | 94 |
| 2022 | 86 |
| 2023 | 42 |
| 2024 | 41 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,541 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 124 |
| GlaxoSmithKline | 121 |
| Hoffmann-La Roche | 92 |
| AstraZeneca | 87 |
| Bayer | 58 |
| Boehringer Ingelheim | 54 |
| Pfizer | 52 |
| Bristol-Myers Squibb | 49 |
| European Organisation for Research and Treatment of Cancer - EORTC | 47 |
| University College, London | 44 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 100 |
| Asthma | 93 |
| Neoplasms | 67 |
| Carcinoma, Non-Small-Cell Lung | 66 |
| Pulmonary Disease, Chronic Obstructive | 63 |
| Diabetes Mellitus, Type 2 | 46 |
| Ovarian Neoplasms | 46 |
| Prostatic Neoplasms | 44 |
| Neoplasm Metastasis | 42 |
| Colorectal Neoplasms | 40 |
Trials
Showing 1 to 25 of 2,541. Each trial links to its page on Pharma Observatory.
2,441 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.